Cat. #151466
Anti-Melphalan-modified DNA [MP5/73]
Cat. #: 151466
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 1-2 weeks
Target: Melphalan
Class: Monoclonal
Application: ELISA ; IHC
Host: Rat
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Michael Tilby
Institute: The Institute of Cancer Research; Newcastle University
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Melphalan-modified DNA [MP5/73]
- Research fields: Cancer;Genetics
- Clone: MP5/73
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Host: Rat
- Application: ELISA ; IHC
- Description: This antibody was developed to improve detection of melphalan-DNA adducts through its ability to recognise the stabilised adduct. This antibody can be used for quantification of melphalan adducts in purified DNA by ELISA and for immunofluorescent detection of melphalan-DNA adducts in single cells.
- Immunogen: Native DNA reacted with melphalan
- Isotype: IgG2b
- Myeloma used: Y3.AG.1.2.3
- Recommended controls: RNA/DNA
Target Details
- Target: Melphalan
- Tissue cell line specificity: RNA/DNA
- Target background: This antibody was developed to improve detection of melphalan-DNA adducts through its ability to recognise the stabilised adduct. This antibody can be used for quantification of melphalan adducts in purified DNA by ELISA and for immunofluorescent detection of melphalan-DNA adducts in single cells.
Applications
- Application: ELISA ; IHC
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
Related Tools
- Related tools: Anti-Melphalan-modified DNA [Amp4/42]
References
- Gould et al. 2004. Mol Pharmacol. 66(5):1301-9. PMID: 15308759.
- p53 elevation in relation to levels and cytotoxicity of mono- and biFn melphalan-DNA adducts.
- Rothbarth et al. 2004. Biochem Pharmacol. 67(9):1771-8. PMID: 15081876.
- Immunohistochemical detection of melphalan-DNA adducts in colon cancer cells in vitro and human colorectal liver tumours in vivo.
- Frank et al. 2003. Exp Cell Res. 283(2):127-34. PMID: 12581733.
- Quantification of DNA adducts in individual cells by immunofluorescence: effects of variation in DNA conformation.
- McCartney et al. 2001. Chem Res Toxicol. 14(1):71-81. PMID: 11170510.
- Antibody recognition of melphalan adducts characterized using immobilized DNA: enhanced alkylation of G-Rich regions in cells compared to in vitro.
- Tilby et al. 1998. Chem Res Toxicol. 11(10):1162-8. PMID: 9778312.
- A monoFn derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts.
- Frank et al. 1996. Blood. 88(3):977-84. PMID: 8704257.
- Detection and quantification of melphalan-DNA adducts at the single cell level in hematopoietic tumor cells.
- Tilby et al. 1993. Eur J Cancer. 29A(5):681-6. PMID: 8471325.
- Application of a sensitive immunoassay to the study of DNA adducts formed in peripheral blood mononuclear cells of patients undergoing high-dose melphalan therapy.
- Tilby et al. 1990. Chem Biol Interact. 73(2-3):183-94. PMID: 2155711.
- Alkylation of DNA by melphalan in relation to immunoassay of melphalan-DNA adducts: characterization of mono-alkylated and cross-linked products from reaction of melphalan with dGMP and GMP.
- Tilby et al. 1987. Cancer Res. 47(6):1542-6. PMID: 3815354.
- Immunological detection of DNA damage caused by melphalan using monoclonal antibodies.
